Clinical and radiological regression of cerebral and spinal metastases of a BRAF V600-mutated malignant melanoma after a single dose of ipilimumab/nivolumab followed by BRAF/MEK inhibition

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Dr. Sera Selina Weyer-Fahlbusch; Dr. Pia Dücker; Prof. Thilo Gambichler; Prof. Laura Susok

Sep 7, 2026